关于 Zoledronic Acid API
CAS 编号
118072-93-8
API 技术
合成
剂型
注射剂
Dr Reddy's 开发状态
可用的
可用的法规申报文件
USDMF, CEP 已提交, 韩国 DMF, 俄罗斯 DMF
Mechanism of Action
Zoledronic acid slows down bone resorption, allowing the bone-forming cells time to rebuild normal bone and allowing bone remodeling
Indication
Reclast is a bisphosphonate indicated for:
- Treatment and prevention of postmenopausal osteoporosis
- Treatment to increase bone mass in men with osteoporosis
- Treatment and prevention of glucocorticoid-induced osteoporosis
- Treatment of Paget’s disease of bone in men and women
Zometa is a bisphosphonate indicated for the treatment of:
- Hypercalcemia of malignancy.
- Patients with multiple myeloma and patients with documented bone metastases from solid tumors, in conjunction with standard antineoplastic therapy. Prostate cancer should have progressed after treatment with at least one hormonal therapy
Request for Quotation
Get in touch with us by filling out the form below. Our team will reach out to you shortly!
Related APIs
免责声明
本網站上的任何信息，包括對任何產品或服務的任何提及，均不構成銷售要約或被解釋為代表銷售要約。受有效專利保護的產品不得提供或供應用於商業用途。但是，在某些情況下，雷迪博士可自行決定並根據當地法律要求，在存在此類監管豁免的任何地方，提供此類產品的研究數量，以根據《印度專利法》第 107A 條（Bolar 豁免）進行監管提交。購買者應對其各自市場的產品或服務（包括專利情況）進行獨立評估，並對所有與專利相關的責任負責。 Dr. Reddy's 不承擔任何明示或暗示的保證，包括但不限於適銷性、適用於特定用途和非侵權的保證。
